Shoulder Innovations Inc(SI) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
September 11 at 4:01 PM ET (Korea 9/12 05:01)
Full metrics table
| Index | RUT | P/E | - | EPS (ttm) | -1.7 | Insider Own | 44.81% | Shs Outstand | 20.8M | Perf Week | -9.12% |
| Market Cap | 0.39B | Forward P/E | - | EPS next Y | 16.43% | Insider Trans | -2.43% | Shs Float | 11.5M | Perf Month | -4.19% |
| Enterprise Value | 0.30B | PEG | - | EPS next Q | -0.51 | Inst Own | 40.06% | Short Float | 2.62% | Perf Quarter | -1.23% |
| Income | -0.04B | P/S | 6.42 | EPS this Y | 59.6% | Inst Trans | 4.55% | Short Ratio | 2.47 | Perf Half Y | 26.74% |
| Sales | 0.06B | P/B | 3.1 | EPS next 5Y | 32.53% | ROA | -30.49% | Short Interest | 0.30M | Perf YTD | 29.58% |
| Book/sh | 5.97 | P/C | 3.9 | EPS past 3/5Y | -75.53% - | ROE | -40.54% | 52W High | -24.66% ($24.59) | Perf Year | 23.53% |
| Cash/sh | 4.75 | P/FCF | - | Sales past 3/5Y | 56.68% - | ROIC | -25.18% | 52W Low | 69.69% ($10.92) | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -7.99% | Gross Margin | 70.53% | Volatility(W/M) | 4.83% 6.02% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | 5.02 | Sales Y/Y TTM | 60.9% | Oper. Margin | -58.53% | ATR (14) | 1.25 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 8.92 | EPS Q/Q | 48.07% | Profit Margin | -58.33% | RSI (14) | 33.77 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 10.71 | Sales Q/Q | 55.95% | SMA20 | -11.49% ($20.94) | Beta | -1.51 | Target Price | $26.25 |
| Payout | - | Debt/Eq | 0.12 | Earnings | 2026/8/6 | SMA50 | -12.73% ($21.23) | Rel Volume | 1.01 | Prev Close | $19.11 |
| Employees | 75 | LT Debt/Eq | 0.12 | EPS/Sales Surpr. | -6.87% 3.71% | SMA200 | 13.15% ($16.38) | Avg Volume(3M) | 0.12M | Price | $18.53 |
| IPO | 2025/7/31 | Option/Short | No/Yes | Trades | 1365 | Volume | 123,496 | Change | -3.04% |
Company
SI is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
A US orthopedic medical device company specializing in shoulder arthroplasty. It focuses on reducing glenoid loosening—a leading cause of shoulder replacement failure—through its patented InSet glenoid design, and is rapidly expanding its surgeon user base in the shoulder replacement market.
Over the past 1 year, roughly in the middle
25% below its 1-year high.
SI has weak earning power
Losses or thin margins. Early-stage growth or weakening competitiveness
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +59.6% this year.
Tap to view numbers
The price looks about right
Trading at - times earnings.
Tap to view numbers
Results came in about as expected
Slight tendency to beat estimates
Tap to view numbers
The outlook is positive
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have paid off
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership looks stable
Institutions hold 40.1%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
LYTE 0.00%
IWC 0.00%
IWM 0.00%
VTWG 0.00%
IWN 0.00%Special products that amplify (leveraged) or invert this single stock. They decay quickly and are not for long-term holding.
GLD 147.4B
IAU 64.7B
SLV 32.4B
GLDM 32.0B
GDX 29.0BIt ranks #4 in the industry
Based on market cap of $386M.
SI $386M PER -
ABT $176B PER 33.0
MDT $116B PER 22.4
SYK $106B PER 28.6
FAQ
What kind of company is SI?
SI belongs to the Healthcare sector and operates in the Medical Devices industry.
What is the market cap of SI?
The market cap of SI is approximately $386M, ranking 3,450 within its sector.
What is the 52-week high and low for SI?
SI has recorded a 52-week high of $24.59 and a low of $10.92.
